What Killed Your First Experiment? The 18-Month Lab Space Delay

by DAVID.KIEWLICH | Aug 21, 2026 | Biotech

Dr. David Kiewlich spent 18 months looking for lab space before he could conduct his first experiment as a founder. That’s 18 months of burn rate and no data. He had to go back to investors and ask for more money to get proof of concept data. His company needed...

Science Doesn’t End at 5:00 PM: Why 24/7 Lab Access Is a Competitive Edge for Biotech Founders

by DAVID.KIEWLICH | Aug 20, 2026 | Biotech

It’s 2:47am. Your cells have reached the exact confluence you need for your assay. Your PCR is done running. Your western blot is ready to image. You have the data you’ve been trying to get for 3 months, and you need to review it. The problem? You’re not allowed...

The Million Dollar Bench: Why Building Your Own Biotech Lab Costs More Than Money—and What To Do Instead

by DAVID.KIEWLICH | Aug 14, 2026 | Biotech

So you’ve got the science down, the vision nailed, and the pitch deck perfected. But what’s stopping you from running your first experiment? It might just be one big, expensive hurdle: a lab. You need a full-on wet lab, complete with biosafety cabinets, CO2...

The Biotech Diversity Gap Is Real. Here’s How One Nonprofit Incubator Is Closing It.

by DAVID.KIEWLICH | Aug 13, 2026 | Biotech

Biotech is the cutting edge of human advancement. Gene therapies are curing rare diseases. Cell-based immunotherapies are redefining oncology. Carbon-capturing biology and engineered materials are shaping climate change. The research has never been more exciting. Yet...

Cheap Cell Therapy Lab Space: Bringing Advanced Therapeutics to Any Budget

by DAVID.KIEWLICH | Jul 24, 2026 | Cell Therapy

The age of cell and gene therapy is here. The FDA has already approved more than 30 cell and gene therapies since 2017, and the global AAV manufacturing market is continuing to expand. Science, however, has outpaced the infrastructure. Before startups run into a...